期刊
NATURE CANCER
卷 1, 期 4, 页码 423-+出版社
NATURE PORTFOLIO
DOI: 10.1038/s43018-019-0020-z
关键词
-
类别
资金
- NIH/NCI Cancer Center Support Grant [P30-CA016672]
- NIH/NCI T32 Award [CA009666]
- University of Texas Southwestern Medical Center [5 P50 CA070907]
- MD Anderson Cancer Center Special Program of Research Excellence [5 P50 CA070907]
- NIH/NCI award [R01-CA207295, U01-CA213273, U01 CA231844, P30CA042014]
- Department of Defense [LC170171]
- ASCO Young Investigator Award
- University of Texas MD Anderson Cancer Center Small Cell Lung Cancer Working Group, Abell Hangar Foundation Distinguished Professor Endowment
- University of Texas MD Anderson Cancer Center Physician Scientist Award
- Hope Foundation SWOG/ITSC Pilot Program
- Andrew Sabin Family Fellowship
- Rexanna's Foundation for Fighting Lung Cancer
The natural history of small-cell lung cancer (SCLC) includes rapid evolution from chemosensitivity to chemoresistance, although mechanisms underlying this evolution remain obscure due to the scarcity of post-relapse tissue samples. We generated circulating tumor cell (CTC)-derived xenografts from patients with SCLC to study intratumoral heterogeneity (ITH) via single-cell RNA sequencing of chemosensitive and chemoresistant CTC-derived xenografts and patient CTCs. We found globally increased ITH, including heterogeneous expression of therapeutic targets and potential resistance pathways, such as epithelial-to-mesenchymal transition, between cellular subpopulations following treatment resistance. Similarly, serial profiling of patient CTCs directly from blood confirmed increased ITH post-relapse. These findings suggest that treatment resistance in SCLC is characterized by coexisting subpopulations of cells with heterogeneous gene expression leading to multiple, concurrent resistance mechanisms. These findings emphasize the need for clinical efforts to focus on rational combination therapies for treatment-naive SCLC tumors to maximize initial responses and counteract the emergence of ITH and diverse resistance mechanisms.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据